Found: 102
Select item for more details and to access through your institution.
Treatment with low‐dose, single‐agent belantamab mafodotin is safe and provides long‐term responses in heavily pretreated multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 367, doi. 10.1111/ejh.14120
- By:
- Publication type:
- Article
The Clinical Significance of Circulating Lymphocytes Morphology in Diffuse Large B-Cell Lymphoma As Determined by a Novel, Highly Sensitive Microscopy.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5611, doi. 10.3390/cancers15235611
- By:
- Publication type:
- Article
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3075, doi. 10.1007/s00277-023-05307-1
- By:
- Publication type:
- Article
Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5205, doi. 10.3390/cancers15215205
- By:
- Publication type:
- Article
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4359, doi. 10.3390/cancers15174359
- By:
- Publication type:
- Article
Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 1, p. 63, doi. 10.1111/ejh.13968
- By:
- Publication type:
- Article
The Role of Extracellular Vesicles (EVs) in Chronic Graft vs. Host Disease, and the Potential Function of Placental Cell-Derived EVs as a Therapeutic Tool.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 8126, doi. 10.3390/ijms24098126
- By:
- Publication type:
- Article
Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5918, doi. 10.3390/ijms24065918
- By:
- Publication type:
- Article
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 149, doi. 10.1111/ejh.13884
- By:
- Publication type:
- Article
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 908, doi. 10.3390/jcm12030908
- By:
- Publication type:
- Article
Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 45, doi. 10.1111/bjh.18479
- By:
- Publication type:
- Article
Lymphoproliferative disease detected by breast cancer screening.
- Published in:
- Journal of Medical Screening, 2022, v. 29, n. 4, p. 255, doi. 10.1177/09691413221109988
- By:
- Publication type:
- Article
Thrombopoietin receptor agonist for treating bone marrow aplasia following anti-CD19 CAR-T cells—single-center experience.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 8, p. 1769, doi. 10.1007/s00277-022-04889-6
- By:
- Publication type:
- Article
Monoclonal gammopathy of renal significance (MGRS): Real‐world data on outcomes and prognostic factors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 877, doi. 10.1002/ajh.26566
- By:
- Publication type:
- Article
REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 471, doi. 10.1002/jha2.403
- By:
- Publication type:
- Article
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
BNT162b2 mRNA COVID‐19 vaccine booster induces seroconversion in patients with B‐cell non‐Hodgkin lymphoma who failed to respond to two prior vaccine doses.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. 1329, doi. 10.1111/bjh.18029
- By:
- Publication type:
- Article
[<sup>18</sup>F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 3, p. 953, doi. 10.1007/s00259-021-05551-5
- By:
- Publication type:
- Article
Characteristics and recognition of early infections in patients treated with commercial anti‐CD19 CAR‐T cells.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 52, doi. 10.1111/ejh.13712
- By:
- Publication type:
- Article
Evaluation of Scopio Labs X100 Full Field PBS: The first high‐resolution full field viewing of peripheral blood specimens combined with artificial intelligence‐based morphological analysis.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 6, p. 1408, doi. 10.1111/ijlh.13681
- By:
- Publication type:
- Article
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients.
- Published in:
- Thrombosis Journal, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12959-021-00333-3
- By:
- Publication type:
- Article
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
- By:
- Publication type:
- Article
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 186, doi. 10.1111/bjh.17608
- By:
- Publication type:
- Article
Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3540, doi. 10.1007/s00259-021-05389-x
- By:
- Publication type:
- Article
Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease.
- Published in:
- Journal of Fungi, 2021, v. 7, n. 9, p. 1, doi. 10.3390/jof7090697
- By:
- Publication type:
- Article
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 4, p. 690, doi. 10.1111/bjh.17527
- By:
- Publication type:
- Article
Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 8, p. 724, doi. 10.3390/jpm11080724
- By:
- Publication type:
- Article
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.646971
- By:
- Publication type:
- Article
Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 945, doi. 10.2147/PPA.S307561
- By:
- Publication type:
- Article
Maternal and neonatal outcomes in 80 patients diagnosed with non‐Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 52, doi. 10.1111/bjh.17103
- By:
- Publication type:
- Article
Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 184, doi. 10.1111/ejh.13535
- By:
- Publication type:
- Article
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 151, n. 2, p. 211, doi. 10.1007/s11060-020-03654-x
- By:
- Publication type:
- Article
Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 1, p. e1, doi. 10.1111/bjh.17105
- By:
- Publication type:
- Article
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211035272
- By:
- Publication type:
- Article
Characteristics and outcomes of adults with cytomegalovirus‐associated thrombocytopenia: a case series and literature review.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 863, doi. 10.1111/bjh.17017
- By:
- Publication type:
- Article
Kinetics of pre‐myelodysplastic syndromes blood values correlate with disease risk and survival.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 782, doi. 10.1002/hon.2777
- By:
- Publication type:
- Article
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bortezomib washout duration prior to stem cell mobilization in patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 30, doi. 10.1111/ejh.13404
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prothrombin Complex Concentrate before Urgent Surgery in Patients Treated with Rivaroxaban and Apixaban.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 3, p. 266, doi. 10.1159/000502173
- By:
- Publication type:
- Article
Real‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 465, doi. 10.1002/ajh.25755
- By:
- Publication type:
- Article
The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. e31, doi. 10.1111/bjh.16422
- By:
- Publication type:
- Article
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolution.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-0756-0
- By:
- Publication type:
- Article
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world Data on Incidence, Clinical Characteristics and Outcome of Patients with Macrofocal Multiple Myeloma in the Novel Therapeutic Era: A study of the Greco-Israeli Collaborative Myeloma Working Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e190, doi. 10.1016/j.clml.2019.09.318
- By:
- Publication type:
- Article
Cryoablative Surgery for Patients with Radiotherapy Resistant Solitary Plasmacytoma: Report of Two Cases.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e191, doi. 10.1016/j.clml.2019.09.320
- By:
- Publication type:
- Article
Treatment Patterns and Clinical Outcomes Across Consecutive Treatment Lines in Multiple Myeloma Patients: Single-Center Real World Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e251, doi. 10.1016/j.clml.2019.09.416
- By:
- Publication type:
- Article
Outcomes of Post-Induction Bortezomib Therapy in Patients with Newly diagnosed Multiple Myeloma: A Multi-Center Retrospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e296, doi. 10.1016/j.clml.2019.09.486
- By:
- Publication type:
- Article